SLE病人外周血sCD28、sCD137水平及临床意义

叶明; 郭术俊; 王成辉; 赵萍; 谢长好; 叶明; 郭术俊; 王成辉; 赵萍; 谢长好

doi:10.13898/j.cnki.issn.1000-2200.2022.10.008

[1]

XIAO ZX, ZHENG SG. The essential role of costimulatory molecules in systemic lupus erythematosus[J]. Lupus, 2019, 28(5): 575. doi: 10.1177/0961203319829818

[2]

MINNING S, XIAOFAN Y, ANQI X, et al. Imbalance between CD8⁺CD28⁺ and CD8⁺CD28^-T-cell subsets and its clinical significance in patients with systemic lupus erythematosus[J]. Lupus, 2019, 28(10): 1214. doi: 10.1177/0961203319867130

[3]

FANOURIAKIS A, KOSTOPOULOU M, ALUNNO A, et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus[J]. Ann Rheum Dis, 2019, 78(6): 736. doi: 10.1136/annrheumdis-2019-215089

[4]

中华医学会风湿免疫学分会. 2020中国系统性红斑狼疮诊疗指南[J]. 中华内科杂志, 2020, 3(59): 172.

[5]

TATIANA NG, TATIANA M, MEGAN MS, et al. CD28 costimulation is essential for human T regulatory expansion and function[J]. Immunol, 2008, 181(4): 2855.

[6]

LAETITIA L, AWENA LF, ROZENN LB, et al. Prevention of lupus nephritis development in NZB/NZW mice by selective blockade of CD28[J]. Eur J Immunol, 2017, 47(8): 1368. doi: 10.1002/eji.201746923

[7]

高元元, 吴俊英, 李柏青, 等. 4-1BBL/4-1BB信号对系统性红斑狼疮患者外周血淋巴细胞活化的影响[J]. 蚌埠医学院学报, 2011, 36(11): 1177.

[8]

MAK A, SCHWARZ H. The progress of investigating the CD137-CD137L axis as a potential target for systemic lupus erythematosus[J]. Cells, 2019, 8(9): 1044. doi: 10.3390/cells8091044

[9]

贾孝云, 翟志成, 谢长好, 等. SLE患者外周血CD4⁺CD28^-、CD4⁺CD28⁺T细胞PD-1的表达及临床意义[J]. 中华微生物学和免疫学杂志, 2018, 38(5): 372.

[10]

ZHOU H, LI B, LI J, et al. Dysregulated T cell activation and aberrant cytokine expression profile in systemic lupus erythematosus[J]. Mediators Inflamm, 2019, 2019: 8450947